期刊
NATURE PROTOCOLS
卷 11, 期 11, 页码 2154-2169出版社
NATURE PORTFOLIO
DOI: 10.1038/nprot.2016.129
关键词
-
资金
- National Research Foundation of Korea (the Bio and Medical Technology Development Program) [2012M3A9B4028631, 2012M3A9C7050126]
- Korean Ministry of Health and Welfare [HI15C0916]
- NIH [GM0099130-01, GM111667-01]
- CSCRF [12-SCB-YALE-11, 13-SCB-YALE-06]
Genome engineering technology using engineered nucleases has been rapidly developing, enabling the efficient correction of simple mutations. However, the precise correction of structural variations (SVs) such as large inversions remains limited. Here we describe a detailed procedure for the modeling or correction of large chromosomal rearrangements and short nucleotide repeat expansions using engineered nucleases in human induced pluripotent stem cells (hiPSCs) from a healthy donor and patients with SVs. This protocol includes the delivery of engineered nucleases with no donor template to hiPSCs, and genotyping and derivation/characterization of gene-manipulated hiPSC clones. With engineered nucleases, genomic inversions, reversions, and deletions of short nucleotide expansions can be identified in 2 weeks, and desired clones can be generated in as little as 3-4 weeks. This protocol enables the correction of large inverted segments and short nucleotide repeat expansions in diseases such as hemophilia A, fragile X syndrome, Hunter syndrome, and Friedreich's ataxia.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据